Skip to content

KYTX - Kyverna Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchK

Kyverna Therapeutics, Inc. Common Stock

KYTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

K

KYTXKyverna Therapeutics, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $13.67
52-wk low: $3.50
Prev close: $8.85
Mkt cap: $548.6M
Beta: 1.94
P/S: 3513.3x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$59.3M

MI
Millennium
Israel Englander · Q2 2026 13F
$5.7M
position
MW
Marshall Wace
Q1 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 6.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $549M

Valuation

P/S3513.34
P/B3.18

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: KYTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $548.55M
Beta: 1.94

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

3.2x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-87.2%

$5.2M

position

DS

D.E. Shaw

Q2 2026 13F

$4.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for KYTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.63+6.0%

-$0.67 expected

Next report

What the street expects next

EPS expected

-$0.74

-$0.79 to -$0.65

Revenue expected

$0.00

4 analysts

Last 30 days

2up2down

Split both ways

-87.2%

ROA-44.5%

Growth

Beta1.94